199 related articles for article (PubMed ID: 3032885)
1. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.
Labro MT; Amit N; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1987 Mar; 19(3):331-41. PubMed ID: 3032885
[TBL] [Abstract][Full Text] [Related]
2. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
Labro MT; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Labro MT; el Benna J
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
[TBL] [Abstract][Full Text] [Related]
4. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
[TBL] [Abstract][Full Text] [Related]
5. Interaction of ceftriaxone with human polymorphonuclear neutrophil function.
Labro MT; Babin-Chevaye C; Pochet I; Hakim J
J Antimicrob Chemother; 1987 Dec; 20(6):849-55. PubMed ID: 2831183
[TBL] [Abstract][Full Text] [Related]
6. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
Braga PC; Dal Sasso M; Mancini L; Sala MT
Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cefotaxime versus desacetyl cefotaxime on human neutrophil functions.
Labro M; Bryskier A
Chemioterapia; 1987 Jun; 6(2 Suppl):237-9. PubMed ID: 3334564
[No Abstract] [Full Text] [Related]
9. Cefodizime enhances phagocytosis and intracellular killing of Staphylococcus aureus but does not influence polymorphonuclear leukocytes response to fMLP stimulation.
Bialasiewicz P; Stolarek R; Wejner P; Piasecka G; Dutkiewicz B; Mikucki J; Nowak D
Int J Immunopharmacol; 2000 Jul; 22(7):557-66. PubMed ID: 10785552
[TBL] [Abstract][Full Text] [Related]
10. In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.
Fietta A; Bersani C; Bertoletti R; Grassi FM; Grassi GG
Chemotherapy; 1988; 34(5):430-6. PubMed ID: 3053065
[TBL] [Abstract][Full Text] [Related]
11. Effect of ceftriaxone-induced alterations of bacteria on neutrophil bactericidal function.
Labro MT; Pochet I; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1987 Dec; 20(6):857-69. PubMed ID: 3326873
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
[TBL] [Abstract][Full Text] [Related]
13. Binding of complement C3 to Klebsiella pneumoniae treated with sub-MIC cefodizime and chemiluminescence response of human polymorphonuclear leukocytes.
Nomura S; Kuroiwa A; Murata K; Nagayama A
Chemotherapy; 1997; 43(2):132-6. PubMed ID: 9084922
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
Wenisch C; Bartunek A; Zedtwitz-Liebenstein K; Hiesmayr M; Parschalk B; Pernerstorfer T; Graninger W
Antimicrob Agents Chemother; 1997 Jul; 41(7):1584-8. PubMed ID: 9210690
[TBL] [Abstract][Full Text] [Related]
15. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
Shaio MF; Chang FY
J Antimicrob Chemother; 1990 Jul; 26(1):55-9. PubMed ID: 2211447
[TBL] [Abstract][Full Text] [Related]
16. Coxiella burnetii fails to stimulate human neutrophil superoxide anion production.
Akporiaye ET; Stefanovich D; Tsosie V; Baca G
Acta Virol; 1990 Feb; 34(1):64-70. PubMed ID: 1975727
[TBL] [Abstract][Full Text] [Related]
17. Electrophoretic mobility of cefodizime-treated Staphylococcus aureus and chemiluminescence of human polymorphonuclear leucocytes.
Muratsugu M; Tomonaga M; Miyake Y; Terayama K; Ishida N
J Antimicrob Chemother; 1991 Dec; 28(6):887-96. PubMed ID: 1816185
[TBL] [Abstract][Full Text] [Related]
18. Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activity.
Amar M; Amit N; Babin-Chevaye C; Huu TP; Hakim J
Infect Immun; 1991 Aug; 59(8):2673-6. PubMed ID: 1855986
[TBL] [Abstract][Full Text] [Related]
19. In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors.
Shin WS; Min CK; Kim YR; Yoo JH; Kang MW
J Antimicrob Chemother; 1996 Jan; 37(1):93-103. PubMed ID: 8647779
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulating effects of cefodizime on Klebsiella pneumoniae-stimulated neutrophils.
Song H; Li G; Ye J; Wan F; Qian Y
Immunobiology; 2004; 209(3):277-82. PubMed ID: 15518339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
